Cyborg bacteria as semi-living organelles for the augmentation of mammalian cells

Synthetic organelles are engineered to replicate the compartmentalization and dynamic functionality of natural organelles, offering the potential to reprogram or rescue cellular functions. Existing approaches, such as protein cages, biomolecular condensates, and other artificial compartments, have shown promise but remain limited by their capacity to perform multifunctional tasks. To overcome these challenges, we introduce Cyborg Bacterial Organelles (CBOs), which are non-replicating, metabolically active bacteria engineered to function as living synthetic organelles within mammalian cells. Unlike synthetic systems or replicating endosymbionts, CBOs integrate the biological complexity of living organisms with the stability and tunability of engineered materials. CBOs are generated by permeating bacteria with poly(ethylene glycol) diacrylate (PEG) based monomers followed by intracellular UV induced hydrogel crosslinking, producing a structurally reinforced, non-replicative chassis capable of sustained activity inside host cells. Here, we show that CBOs remained detectable inside mammalian cells with substantially reduced morphological disruption compared with wild-type bacteria. Furthermore, we show that CBOs can perform complex functions intracellularly, including responses to extracellular chemical stimuli via synthetic gene circuits and execution of enzymatic reactions such as prodrug conversion into a therapeutic drug. Notably, we also show that CBOs protect host cells from chemically induced mitochondrial stress. Transcriptomic analysis revealed host gene expression changes associated with membrane remodeling, ion transport, and metabolic buffering, suggesting that CBOs modulate the host in protective and adaptive ways. Together, these findings establish CBOs as a novel hybrid material platform for intracellular engineering while addressing key limitations of current synthetic organelle systems. CBOs open new possibilities for cellular modulation in therapeutic and diagnostic applications.

Authors

Institutions

Publication Details

Journal
Bioactive Materials
Published
2026-11-14
DOI
https://doi.org/10.1016/j.bioactmat.2026.10.005
Primary Topic
Bacterial Cancer Therapy
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Cyborg bacteria as semi-living organelles for the augmentation of mammalian cells

Cheemeng Tan, Russell C. Hovey, Ofelya Baghdasaryan, Jared Lee-Kin
Bioactive Materials
Bacterial Cancer Therapy
article

Cyborg bacteria as semi-living organelles for the augmentation of mammalian cells

Cheemeng Tan, Russell C. Hovey, Ofelya Baghdasaryan, Jared Lee-Kin
article en

Abstract

Synthetic organelles are engineered to replicate the compartmentalization and dynamic functionality of natural organelles, offering the potential to reprogram or rescue cellular functions. Existing approaches, such as protein cages, biomolecular condensates, and other artificial compartments, have shown promise but remain limited by their capacity to perform multifunctional tasks. To overcome these challenges, we introduce Cyborg Bacterial Organelles (CBOs), which are non-replicating, metabolically active bacteria engineered to function as living synthetic organelles within mammalian cells. Unlike synthetic systems or replicating endosymbionts, CBOs integrate the biological complexity of living organisms with the stability and tunability of engineered materials. CBOs are generated by permeating bacteria with poly(ethylene glycol) diacrylate (PEG) based monomers followed by intracellular UV induced hydrogel crosslinking, producing a structurally reinforced, non-replicative chassis capable of sustained activity inside host cells. Here, we show that CBOs remained detectable inside mammalian cells with substantially reduced morphological disruption compared with wild-type bacteria. Furthermore, we show that CBOs can perform complex functions intracellularly, including responses to extracellular chemical stimuli via synthetic gene circuits and execution of enzymatic reactions such as prodrug conversion into a therapeutic drug. Notably, we also show that CBOs protect host cells from chemically induced mitochondrial stress. Transcriptomic analysis revealed host gene expression changes associated with membrane remodeling, ion transport, and metabolic buffering, suggesting that CBOs modulate the host in protective and adaptive ways. Together, these findings establish CBOs as a novel hybrid material platform for intracellular engineering while addressing key limitations of current synthetic organelle systems. CBOs open new possibilities for cellular modulation in therapeutic and diagnostic applications.

Bioactive MaterialsVol. 69
University of California, Davis (US)
National Institute of General Medical Sciences
Bacterial Cancer Therapy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon